1

2

3

4

5

6
Dixon Julie, Dumas Jacques, Brennan Catherine, Hatoum Mokdad Holia, Lee Wendy, Sibley Robert, Bear Brian, Chandler Brent, Miranda Karl, Chen Gang, Chen Zhi, Brittelli David, Clark Roger B: 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors. Bayer Pharmaceuticals Corporation, Dixon Julie, Dumas Jacques, Brennan Catherine, Hatoum Mokdad Holia, Lee Wendy, Sibley Robert, Bear Brian, Chandler Brent, Miranda Karl, Chen Gang, Chen Zhi, Brittelli David, Clark Roger B, GREENMAN Jeffrey M, April 3, 2003: WO/2003/026666 (3 worldwide citation)

The invention provides novel substituted 2,4-diaminopyrimidine compounds (I), in which L is a linker selected from: -O-(CH¿2?)¿1-4?- ; s(O)¿0-2?-(CH¿2?)¿1-4?- ; -N(R?1¿)-(CH¿2?)¿1-4?-(CH¿2?)¿1-4?-O-(CH¿2?)¿1-4?- ; -N(R?1¿)-C(O)-(CH¿2?)¿1-4?- ; (I) and (I) G represents: Alternatively, L may represent ...